Table 3.
Compd | IC50 (μM)a | IC50 (μM)b |
---|---|---|
76 | > 100 | > 100 |
77 | > 100 | > 100 |
78 (4′-ethynylstavudine) | 0.20 | > 100 |
stavudine | 2.8 | 100 |
Data taken from ref. 33.
Inhibitory concentration required to achieve 50% protection of MT-2 cells against the cytopathic effect of HIV-1 IIIB.
Cytotoxic concentration required to reduce the viability of mock-infected MT-2 cells by 50%.